Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Correspondence] Time to recognise countries’ preferences in HIV control

While The Lancet stated that the new WHO antiretroviral therapy (ART) guidelines are ambitious,1 Granich and Williams (Jan 2, p 27) called for the implementation of a “test-and-treat strategy” to achieve the goals of the 90-90-90 target and epidemic control.2 They stated that this strategy fits within the global budget and implied that countries’ HIV budgets should be first and foremost spent on putting all individuals with HIV on ART. However, their suggestions overlooked HIV control preferences at the country level, where goals other than epidemic control might also be considered important.